Crossmark Global Holdings’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
QCM
YCM
EWM
MFG
COPPSERS
LTAS
CPBTD
GI
Crossmark Global Holdings's ACLS Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Axcelis (ACLS) stake by 14% in Q2 2026, selling an estimated $48.8K and leaving 2,001 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #975.
Crossmark Global Holdings first reported a position in ACLS in Q4 2017 and has held it in 17 quarters since. The position peaked at $504K in Q4 2017. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Crossmark Global Holdings held 2,001 shares of Axcelis worth $379K as of Q2 2026.
- Crossmark Global Holdings sold 329 Axcelis shares in Q2 2026, an estimated $48.8K.
- Axcelis made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #975 holding.
- Crossmark Global Holdings first reported a position in Axcelis in Q4 2017 and has held it in 17 quarters since.
- Crossmark Global Holdings's Axcelis position peaked at $504K in Q4 2017.
- 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.